162 related articles for article (PubMed ID: 15789613)
21. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Bauer RF; Leonard R; Abe Y; Nicolaou KC
Prostaglandins; 1989 Feb; 37(2):287-302. PubMed ID: 2543037
[TBL] [Abstract][Full Text] [Related]
22. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
23. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
[TBL] [Abstract][Full Text] [Related]
24. Biologic properties of LTB4 and paf-acether in vivo in human skin.
Michel L; Mencia-Huerta JM; Benveniste J; Dubertret L
J Invest Dermatol; 1987 Jun; 88(6):675-81. PubMed ID: 3035030
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
[TBL] [Abstract][Full Text] [Related]
26. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro.
Foster AP; Lees P; Cunningham FM
Res Vet Sci; 1992 Sep; 53(2):223-9. PubMed ID: 1332153
[TBL] [Abstract][Full Text] [Related]
27. Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4.
Steel HC; Tintinger GR; Theron AJ; Anderson R
Clin Exp Immunol; 2007 Oct; 150(1):144-50. PubMed ID: 17683509
[TBL] [Abstract][Full Text] [Related]
28. Phorbol 12-myristate 13-acetate inhibits binding of leukotriene B4 and platelet-activating factor and the responses they induce in neutrophils: site of action.
Yamazaki M; Gomez-Cambronero J; Durstin M; Molski TF; Becker EL; Sha'afi RI
Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5791-4. PubMed ID: 2548188
[TBL] [Abstract][Full Text] [Related]
29. Chemotactic peptide down-regulation of calcium mobilization induced by platelet-activating factor and by leukotriene B4 in human neutrophils is uncovered by protein phosphatase inhibitors.
Montero M; Garcia-Sancho J; Alverez J
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):559-66. PubMed ID: 7980418
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
[TBL] [Abstract][Full Text] [Related]
31. Degree of neutrophil chemotaxis is dependent upon the chemoattractant and barrier.
Casale TB; Abbas MK; Carolan EJ
Am J Respir Cell Mol Biol; 1992 Jul; 7(1):112-7. PubMed ID: 1320901
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of leukotriene B4-induced increase in intracellular calcium ion level of human peripheral blood polymorphonuclear leukocytes by Y-24180, an antagonist of platelet-activating factor receptor.
Komatsu H; Amano M
Int J Immunopharmacol; 1997; 19(11-12):661-7. PubMed ID: 9669206
[TBL] [Abstract][Full Text] [Related]
33. PAF and LTB4 biosynthesis in the human neutrophil: effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase.
Glaser KB; Lock YW; Chang JY
Agents Actions; 1991 Sep; 34(1-2):89-92. PubMed ID: 1665306
[TBL] [Abstract][Full Text] [Related]
34. The inhibitory effect of methotrexate on PAF-induced neutrophil and eosinophil locomotion in asthmatic patients.
Tsai JJ; Wang TF; Wang SR
Asian Pac J Allergy Immunol; 1994 Jun; 12(1):65-71. PubMed ID: 7872994
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory chemoreceptor cross-talk suppresses leukotriene B4 receptor 1-mediated neutrophil calcium mobilization and chemotaxis after trauma.
Tarlowe MH; Kannan KB; Itagaki K; Adams JM; Livingston DH; Hauser CJ
J Immunol; 2003 Aug; 171(4):2066-73. PubMed ID: 12902512
[TBL] [Abstract][Full Text] [Related]
36. Systematic single cell analysis of migration and morphological changes of human neutrophils over stimulus concentration gradients.
Yamauchi A; Degawa-Yamauchi M; Kuribayashi F; Kanegasaki S; Tsuchiya T
J Immunol Methods; 2014 Feb; 404():59-70. PubMed ID: 24370750
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression.
Gabrijelcic J; Acuña A; Profita M; Paternò A; Chung KF; Vignola AM; Rodríguez-Roisin R
Eur Respir J; 2003 Aug; 22(2):290-7. PubMed ID: 12952263
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
39. Modulation of leukotriene B4 receptor 1 signaling by receptor for advanced glycation end products (RAGE).
Ichiki T; Koga T; Okuno T; Saeki K; Yamamoto Y; Yamamoto H; Sakaguchi M; Yokomizo T
FASEB J; 2016 May; 30(5):1811-22. PubMed ID: 26813973
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil aggregating properties of PAF-acether and leukotriene B4.
Ford-Hutchinson AW
Int J Immunopharmacol; 1983; 5(1):17-21. PubMed ID: 6302012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
